Abstract P4-10-09: Patient-centered dosing: Oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC)
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs21-p4-10-09
Abstract: Background: MBC is generally incurable and most patients will remain on treatment indefinitely. Medical oncologists commonly prescribe the Recommended Starting Dose (RSD) from the FDA-approved label based upon clinical trial results, with lower doses typically… read more here.
Keywords: medical oncologists; centered dosing; patient centered; treatment related ... See more keywords